Company profile · Ingelheim am Rhein, Germany

Boehringer Ingelheim

Biopharmaceutical Production and Therapeutic Manufacturing · Global therapeutic manufacturing

Verified 14 Mar 2026 · 3 sources

BiologicsAPI SynthesisFill-finishCommercial
GermanyTherapeuticsIngelheim am Rhein

Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.

Lead
Hubertus von Baumbach (verified ↗)
Compliance
GMP Manufacturing
Last reviewed
14 Mar 2026 (3mo ago)
Scale
Global therapeutic manufacturing
Capabilities
Biopharmaceutical Production · Small-Molecule Manufacturing · Global Fill-Finish and Supply Operations
Founded
1885
Headcount
10000+
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Hubertus von Baumbach

Chairman of the Board of Managing Directors

Check official leadership source
Full addressBinger Straße 173, 55216 Ingelheim am Rhein, Germany
Site coordinates49.974250, 8.117803
Review cycleMay 2026
Physical site source

Official Boehringer Ingelheim contact page listing Binger Straße 173, Ingelheim am Rhein.

Open source
Operating profile

Global therapeutic manufacturing

Ingelheim am Rhein, Germany. Biopharmaceutical Production and Therapeutic Manufacturing. Review completed on 14 Mar 2026.

2026 technical specializationBiopharmaceutical Production and Therapeutic Manufacturing
Core capabilities
Biopharmaceutical ProductionSmall-Molecule ManufacturingGlobal Fill-Finish and Supply Operations
Governance

EMA, FDA, and German pharmaceutical oversight

GMP Manufacturing, Global Quality and Production Network

Editorial note

Biopharmaceutical Production and Therapeutic Manufacturing

Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.

Editorial note

Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 14 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Biopharmaceutical Production
Small-Molecule Manufacturing
Global Fill-Finish and Supply Operations
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceBoehringer Ingelheim official leadership source naming Hubertus von Baumbach.Source origin: boehringer-ingelheim.comOpen source
Supporting evidenceBoehringer Ingelheim annual-report production overview outlining the company's research, development, and production network.Source origin: boehringer-ingelheim.comOpen source
Physical-site evidenceOfficial Boehringer Ingelheim contact page listing Binger Straße 173, Ingelheim am Rhein.Source origin: boehringer-ingelheim.comOpen source
Infrastructure

Declared infrastructure

Biopharmaceutical production suites
Fill-finish operations
Analytical and quality-control laboratories
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
VERIFIED ACTIVE 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
REVIEW IN PROGRESS 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is Boehringer Ingelheim located?
Boehringer Ingelheim operates from Binger Straße 173, 55216 Ingelheim am Rhein, Germany, Ingelheim am Rhein, Germany.
Who runs Boehringer Ingelheim?
Boehringer Ingelheim is led by Hubertus von Baumbach, Chairman of the Board of Managing Directors. Verified 14 Mar 2026.
What certifications does Boehringer Ingelheim hold?
Boehringer Ingelheim is documented under GMP Manufacturing.
What does Boehringer Ingelheim do?
Boehringer Ingelheim joins the verified German core through a current official leadership surface and annual-report production disclosure. Core capabilities: Biopharmaceutical Production, Small-Molecule Manufacturing, Global Fill-Finish and Supply Operations.
Editorial context

Related technical briefs

Briefs that name Ingelheim am Rhein as a covered market or city.